Insider Trading & Ownership - FONTEYNE PAUL R.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for FONTEYNE PAUL R.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-01-06
Purchase
2022-01-10
8:37 pm
Amylyx Pharmaceuticals Inc.AMLXFONTEYNE PAUL R.
Director
3,947$19$74,99312,347
(Direct)
View
2021-08-10
Purchase
2021-08-11
4:09 pm
COVETRUS INC.CVETFONTEYNE PAUL R.
Director
5,000$23.24$116,2005,000
(Direct)
View
2020-05-08
Purchase
2020-05-12
5:53 pm
Apellis Pharmaceuticals Inc.APLSFONTEYNE PAUL R.
Director
5,000$31.81$159,0345,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-06
Option Award
2024-06-07
4:52 pm
N/A
2034-06-05
Amylyx Pharmaceuticals Inc.AMLXFONTEYNE PAUL R.
Director
25,000$025,000
(Direct)
View
2024-01-01
Option Award
2024-01-02
4:13 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSFONTEYNE PAUL R.
Director
3,341$022,186
(Direct)
View
2024-01-01
Option Award
2024-01-02
4:13 pm
N/A
2030-12-31
Apellis Pharmaceuticals Inc.APLSFONTEYNE PAUL R.
Director
5,748$59.8622,186
(Direct)
View
2023-06-08
Option Award
2023-06-12
7:34 pm
N/A
2033-06-08
Amylyx Pharmaceuticals Inc.AMLXFONTEYNE PAUL R.
Director
16,985$016,985
(Direct)
View
2023-01-01
Option Award
2023-01-04
5:31 pm
N/A
2030-12-31
Apellis Pharmaceuticals Inc.APLSFONTEYNE PAUL R.
Director
11,308$020,538
(Direct)
View
2022-10-13
Disposition
2022-10-13
11:03 am
N/A
N/A
COVETRUS INC.CVETFONTEYNE PAUL R.
Director
27,913$00
(Direct)
View
2022-07-01
Exercise
2022-07-06
4:06 pm
N/A
2022-07-01
COVETRUS INC.CVETFONTEYNE PAUL R.
Director
8,275$013,275
(Direct)
View
2022-06-09
Option Award
2022-06-10
4:05 pm
N/A
2032-06-09
Amylyx Pharmaceuticals Inc.AMLXFONTEYNE PAUL R.
Director
19,000$019,000
(Direct)
View
2022-05-11
Option Award
2022-05-13
4:10 pm
N/A
N/A
COVETRUS INC.CVETFONTEYNE PAUL R.
Director
14,638$014,638
(Direct)
View
2022-05-06
Option Award
2022-05-09
4:17 pm
N/A
N/A
GELESIS HOLDINGS INC.GLSFONTEYNE PAUL R.
Director
53,832$053,832
(Direct)
View

Ownership
2022-01-24
4:39 pm
N/A
2027-01-13
GELESIS HOLDINGS INC.GLSFONTEYNE PAUL R.
Director
0$0292,687
(Direct)
View
2022-01-06
Option Award
2022-01-10
8:37 pm
N/A
2032-01-06
Amylyx Pharmaceuticals Inc.AMLXFONTEYNE PAUL R.
Director
8,400$012,347
(Direct)
View

Ownership
2022-01-06
5:06 pm
N/A
2031-03-23
Amylyx Pharmaceuticals Inc.AMLXFONTEYNE PAUL R.
Director
0$081,100
(Direct)
View
2022-01-01
Option Award
2022-01-04
9:28 pm
N/A
2029-12-31
Apellis Pharmaceuticals Inc.APLSFONTEYNE PAUL R.
Director
12,784$017,784
(Direct)
View
2021-07-01
Option Award
2021-07-06
4:03 pm
N/A
2022-07-01
COVETRUS INC.CVETFONTEYNE PAUL R.
Director
8,275$08,275
(Direct)
View
2021-01-01
Option Award
2021-01-04
7:31 pm
N/A
2030-12-31
Apellis Pharmaceuticals Inc.APLSFONTEYNE PAUL R.
Director
27,600$027,600
(Direct)
View
2020-11-16
Disposition
2020-11-17
3:40 pm
N/A
N/A
AMAG PHARMACEUTICALS INC.AMAGFONTEYNE PAUL R.
Director
51,417$00
(Direct)
View
2020-06-03
Option Award
2020-06-05
4:32 pm
N/A
2030-06-02
resTORbio Inc.TORCFONTEYNE PAUL R.
Director
14,414$014,414
(Direct)
View
2020-06-02
Option Award
2020-06-04
4:49 pm
N/A
2030-06-02
AMAG PHARMACEUTICALS INC.AMAGFONTEYNE PAUL R.
Director
31,558$035,965
(Direct)
View
2020-04-02
Option Award
2020-04-06
5:37 pm
N/A
2030-04-01
Apellis Pharmaceuticals Inc.APLSFONTEYNE PAUL R.
Director
37,500$037,500
(Direct)
View